Search results for "Follow-Up Studie"

showing 10 items of 2217 documents

The Mediterranean diet, plasma metabolome, and cardiovascular disease risk.

2020

Abstract Aims To investigate whether metabolic signature composed of multiple plasma metabolites can be used to characterize adherence and metabolic response to the Mediterranean diet and whether such a metabolic signature is associated with cardiovascular disease (CVD) risk. Methods and results Our primary study cohort included 1859 participants from the Spanish PREDIMED trial, and validation cohorts included 6868 participants from the US Nurses’ Health Studies I and II, and Health Professionals Follow-up Study (NHS/HPFS). Adherence to the Mediterranean diet was assessed using a validated Mediterranean Diet Adherence Screener (MEDAS), and plasma metabolome was profiled by liquid chromatogr…

medicine.medical_specialtyMediterranean dietbusiness.industryIncidence (epidemiology)Hazard ratioDiseaseOdds ratio030204 cardiovascular system & hematologyDiet Mediterranean03 medical and health sciences0302 clinical medicineCardiovascular DiseasesRisk FactorsInternal medicineCohortMendelian randomizationMetabolomemedicineMetabolomeHumans030212 general & internal medicineCardiology and Cardiovascular MedicinebusinessFollow-Up StudiesGenome-Wide Association StudyEuropean heart journal
researchProduct

An unusual otomicroscopy diagnosis.

2003

medicine.medical_specialtyMicroscopyTympanic Membranebusiness.industryOtoscopyDermatologySensitivity and SpecificityCongenital AbnormalitiesBranchial RegionOtorhinolaryngologyMedicineHumansSurgeryFemalebusinessChildFollow-Up StudiesOtolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery
researchProduct

Prevention and management of musculoskeletal pain in nursing staff by a multifaceted intervention in the workplace: design of a cluster randomized co…

2018

Musculoskeletal pain (MSP) is the leading cause of years lived with disability. In consequence, to reduce MSP and its associated sickness absence is a major challenge. Previous interventions have been developed to reduce MSP and improve return to work of workers with MSP, but combined approaches and exhaustive evaluation are needed. The objective of the INTEVAL_Spain project is to evaluate the effectiveness of a multifaceted intervention in the workplace to prevent and manage MSP in nursing staff. The study is designed as a two-armed cluster randomized controlled trial with a late intervention control group. The hospital units are the clusters of randomization and participants are nurses an…

medicine.medical_specialtyMultifaceted interventionReturn to workCost-Benefit AnalysisMusculoskeletal painPsychological intervention030209 endocrinology & metabolismContext (language use)Nursing Staff HospitalCluster randomized controlled triallaw.inventionCase management03 medical and health sciencesStudy Protocol0302 clinical medicineRandomized controlled triallawIntervention (counseling)Surveys and QuestionnairesSick leavemedicineHumans030212 general & internal medicineOccupational Healthbusiness.industryPublic healthlcsh:Public aspects of medicinePublic Health Environmental and Occupational Healthlcsh:RA1-1270Participatory ergonomicsHealth promotionResearch DesignSpainFamily medicineEconomic evaluationHealth promotionErgonomicsbusinessFollow-Up StudiesBMC public health
researchProduct

Treatment of multiple sclerosis with interferon beta in clinical practice: 2-year follow-up data from the South Italy Mobile MRI Project.

2006

This follow-up study assessed the 2-year clinical and magnetic resonance imaging (MRI) outcomes of patients with multiple sclerosis (MS) originally enrolled in an MRI study conducted at eight centres in south Italy (the South Italy Mobile MRI Project). Of the 597 MS patients recruited at baseline, 391 returned for the follow-up study. Of these, 363 provided 2-year clinical and MRI follow-up data, and 215 were still undergoing treatment with one of four interferon beta regimens: Avonex, 30 mcg intramuscularly once weekly; Betaferon, 250 mcg subcutaneously (sc) every other day; Rebif 22 mcg sc three times weekly (tiw; Rebif 22); or Rebif 44 mcg sc tiw (Rebif 44). Over the 2-year follow-up per…

medicine.medical_specialtyNeurologyMultiple SclerosisDermatologySeverity of Illness IndexInterferon beta • Multiple sclerosis • Phase IV • Odds ratioInternal medicineSeverity of illnessmedicineConfidence IntervalsHumansImmunologic FactorsMultiple sclerosiNeuroradiologyAnalysis of Variancemedicine.diagnostic_testbusiness.industryMultiple sclerosisMagnetic resonance imagingGeneral MedicineOdds ratioInterferon-betaOdds ratiomedicine.diseaseInterferon betaMagnetic Resonance ImagingConfidence intervalPsychiatry and Mental healthItalyPhysical therapySettore MED/26 - NeurologiaNeurology (clinical)NeurosurgeryPhase IVbusinessFollow-Up Studies
researchProduct

Pubertal maturation in girls treated for childhood acute leukaemia.

1991

Eleven girlds treated during childhood for acute leukaemia were followed up during their pubertal development. At each examination weight, height, pubertal stage, FSH, LH, oestradiol, testosterone, androstenedione and dehydroepiandrosterone sulphate levels were evaluated. Clinical and endocrinological studies were performed according to age and pubertal stage and compared to those of healthy girls matched for age and pubertal stage. Results showed that pubertal maturation and gonadal function were not affected by oncotherapy; however menarche was attained earlier. Early menarche was explained by the overweight of treated girls during early puberty. No evidence of early hypothalamic activati…

medicine.medical_specialtyOverweightPubertal stageEarly menarcheInternal medicineMedicineEndocrine systemHumansAndrostenedioneChildTestosteroneMenarchebusiness.industryBody WeightPubertyAge FactorsPrecursor Cell Lymphoblastic Leukemia-LymphomaBody HeightHormonesLeukemia Myeloid AcuteEndocrinologyEl NiñoChild PreschoolPediatrics Perinatology and Child HealthMenarcheFemalemedicine.symptombusinessFollow-Up StudiesEuropean journal of pediatrics
researchProduct

Esophageal cancer: Clinical Practice Guidelines for diagnosis, treatment and follow-up

2010

Esophageal cancer: Clinical Practice Guidelines for diagnosis, treatment and follow-up M. Stahl, W. Budach, H.-J. Meyer & A. Cervantes On behalf of the ESMO Guidelines Working Group* Department of Medical Oncology and Centre of Palliative Care, Kliniken Essen-Mitte, Essen; Department of Radiation Oncology, University of Dusseldorf, Dusseldorf; Department of Surgery, Stadt Klinikum Solingen, Germany; Department of Hematology and Medical Oncology, INCLIVA, University of Valencia, Valencia, Spain

medicine.medical_specialtyPalliative careEsophageal NeoplasmsMeta-Analysis as TopicRadiation oncologymedicineHumansNeoplasm MetastasisNeoplasm StagingEsophageal diseasebusiness.industryIncidenceGeneral surgeryFollow up studiesCancerHematologyEsophageal cancermedicine.diseasehumanitiesSurgeryEsophagectomyEuropeClinical PracticeTreatment OutcomeClinical Trials Phase III as TopicOncologyDiagnosis treatmentEsophagoscopybusinessFollow-Up StudiesAnnals of Oncology
researchProduct

Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

2010

Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up A. Okines, M. Verheij, W. Allum, D. Cunningham & A. Cervantes On behalf of the ESMO Guidelines Working Group* GI Clinical Trials Unit, Royal Marsden Hospital, Sutton, UK; Department of Radiation Oncology and Division of Cellular Biochemistry, The Netherlands Cancer Institute—Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; Department of Surgery, Royal Marsden Hospital, London; Department of Medicine, Royal Marsden Hospital, Sutton, UK; Department of Hematology and Medical Oncology, INCLIVA, University of Valencia, Valencia, Spain

medicine.medical_specialtyPalliative careTreatment outcomeMeta-Analysis as TopicStomach NeoplasmsAntineoplastic Combined Chemotherapy ProtocolsGastroscopyRadiation oncologyEpidemiologymedicineHumansNeoplasm MetastasisNeoplasm StagingRandomized Controlled Trials as TopicRadiotherapybusiness.industryIncidenceGeneral surgeryPalliative CareCancerHematologymedicine.diseaseCombined Modality TherapySurvival AnalysishumanitiesSurgeryEuropeClinical PracticeTreatment OutcomeOncologyClinical trials unitDiagnosis treatmentChemotherapy AdjuvantbusinessFollow-Up StudiesAnnals of Oncology
researchProduct

Neurophysiological evaluation of visual function in iRBD: potential role in stratifying RBD conversion risk.

2021

Abstract Study objectives To evaluate neurophysiological alterations of visual function in idiopathic REM sleep Behavior Disorder (iRBD) both as markers and predictors of neurodegenerative disorders. Methods In a longitudinal follow-up study of 46 consecutive iRBD patients (follow-up duration 8.4 ± 3.4 years), the baseline parameters in luminance-contrast pattern (VEPp), red-green color (VEPc) and motion-onset (VEPm) Visual Evoked Potentials in iRBD were compared to early (ePD) and advanced (aPD) Parkinson's Disease subjects. Parameters of latency and amplitude of iRBD converters to neurodegenerative disease were compared with those of the non-converters. Results The VEP P100 mean latency v…

medicine.medical_specialtyParkinson's diseasegenetic structuresEvoked potentials; Neurodegenerative disorders; Neurophysiology; Parkinson's disease; Phenoconversion risk; REM sleep Behavior disorderParkinson's diseaseNeurophysiologyVisual evoked potentialsREM Sleep Behavior DisorderAudiologyREM sleep behavior disorder03 medical and health sciences0302 clinical medicinemedicineHumansbusiness.industryNeurodegenerative DiseasesParkinson DiseaseGeneral MedicineEvoked potentialsNeurophysiologymedicine.disease030228 respiratory systemVisual functionNeurodegenerative disordersEvoked Potentials VisualPhenoconversion riskbusiness030217 neurology & neurosurgeryFollow-Up StudiesSleep medicine
researchProduct

Deflazacort in Duchenne dystrophy: Study of long-term effect

1994

A randomized double-blind controlled trial of deflazacort was conducted in 28 Duchenne muscular dystrophy patients either treated with deflazacort 2.0 mg/kg alternate-day therapy or placebo. The deflazacort group showed significant improvement in climbing stairs (P < 0.01), in rising from a chair, Gower's maneuver, and walking (P < 0.0025) after 6 months of treatment. After 1 year, all the above changes remained significantly improved and the MRC index was significantly better (P < 0.05) in the treated group. After 2 years, a significant change was found in the MRC index: higher scores in walking, chair rising (P < 0.02), and grade and time of Gower's maneuver (P < 0.05) were found. The mea…

medicine.medical_specialtyPatient DropoutsTime Factorsmedicine.drug_classPhysiologyDuchenne muscular dystrophymedicine.medical_treatmentMotor ActivityPlaceboMuscular Dystrophieslaw.inventionCellular and Molecular NeuroscienceDouble-Blind MethodRandomized controlled trialPregnenedioneslawPhysiology (medical)medicineHumansChildGaitChemotherapybusiness.industryMusclesAnti-Inflammatory Agents Non-SteroidalBody Weightmedicine.diseaseSurgeryClinical trialDeflazacortAnesthesiaCorticosteroidNeurology (clinical)medicine.symptombusinessWeight gainFollow-Up Studiesmedicine.drugMuscle &amp; Nerve
researchProduct

Extracorporeal shock wave lithotripsy of urinary calculi: experience in treatment of 3,278 patients using the Siemens Lithostar and Lithostar Plus.

1991

Between March 1986 and June 1989, 3,278 patients with upper urinary tract calculi were treated at our medical center with the Lithostar lithotriptor. The stones were located in the calices in 41.9% of the cases, renal pelvis in 25.7% and ureter in 32.4%. Perirenal hematoma was noted in 0.5% of the patients but this resolved spontaneously within a few days. Auxiliary procedures were performed in 37.3% of the cases, including Double-J stent and ureteral catheter in 26.8%, ureterorenoscopy in 2.1%, percutaneous nephrostomy in 1.6%, Zeiss loop in 4.3% and percutaneous nephrolithotripsy in 3.5%. Of the treatments 83.1% were performed without general or regional anesthesia. Followup after 3 month…

medicine.medical_specialtyPercutaneousUreteral Calculibusiness.industryUrologymedicine.medical_treatmentUrinary systemEndoscopyLithotripsyExtracorporeal shock wave lithotripsySurgeryKidney Calculimedicine.anatomical_structureUreterPercutaneous nephrostomyLithotripsyMedicineHumansStentsbusinessUrinary CatheterizationRenal pelvisUpper urinary tractFollow-Up StudiesNephrostomy PercutaneousThe Journal of urology
researchProduct